• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Actinium Pharma released FY2025 9 Months Earnings on November 14 EST, with actual revenue of USD 90 K and EPS of USD -0.8958
04:00
Actinium Pharma released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 90K, actual EPS USD -0.1644 (forecast EPS USD -0.3025)
04:00
Oct28
Jason McCarthy Issues Buy Rating on Actinium Pharmaceuticals
15:57
Oct15
Jason McCarthy Gives Actinium Pharmaceuticals a Buy Rating
15:37
Aug9
Actinium Pharma released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2204 (forecast USD -0.346)
03:00
Actinium Pharma released FY2025 Semi-Annual earnings on August 8 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.7313 (forecast USD -0.83)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 90 K, Net Income -5.131 M, EPS -0.1644

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.878 M, EPS -0.2204

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -15.94 M, EPS -0.5109

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
WAI
3.360
+32.28%
+0.820
View More